Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other financing activities (2017 - 2025)

Cytosorbents' Other financing activities history spans 7 years, with the latest figure at $886000.0 for Q4 2025.

  • Quarterly results put Other financing activities at $886000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.8 million (changed N/A YoY), and the annual figure for FY2025 was $2.8 million, down 26.46%.
  • Other financing activities for Q4 2025 was $886000.0 at Cytosorbents, up from $488000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $886000.0 in Q4 2025 to a low of $488000.0 in Q3 2025.